The content on this site is intended for healthcare professionals only
Prof Cengiz Yakicier spoke to ecancer at the BGICC 2020 conference in Cairo, Egypt about advances in genomic technologies.
He outlines the importance and use of genomic profiling, and also how a decrease in cost is leading to more accessible personalised medicine.
Hormonal receptor positive breast cancer adjuvant and metastatic indications
Synthetic biology and precision medicine in blood and gynaecological cancers
First-line NALIRIFOX shows improvement in OS and PFS in metastatic pancreatic cancer
Breast and emerging indications for IORT
The advantages of IORT for early breast cancer treatment
The pros and cons of breast IORT and ultra hypofractionation (FR)
SOFT study: Clinical relevance of genomic alterations in premenopausal HR+, HER2- early breast cancer
Global adoption of single-shot targeted IORT for breast cancer
The advancements in radiotherapy for breast cancer patients
